share_log

康方生物:自願公告 - 國家藥品監督管理局已正式受理康方生物自主研發的伊努西單抗注射液(抗PCSK9單克隆抗體,AK102)的新藥上市申請

AKESO: VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION HAS ACCEPTED THE NEW DRUG APPLICATION FOR EBRONUCIMAB INJECTION (ANTI-PCSK9 MONOCLONAL ANTIBODY, AK102) DEVELOPED BY AKESO

香港交易所 ·  Jun 1, 2023 20:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more